Dr Judith Favier

Judith Favier was trained as molecular and cellular biologist during her PhD in the Coll├Ęge de France (Paris) and as a post-doctoral fellow at the Montreal Heart Institute (Canada). She focused on the study of HIF2alpha and its role in angiogenesis. She now holds a Research Director position in the French National Institute of Health and Medical Research (INSERM) and leads with Anne-Paule Gimenez-Roqueplo a research team dedicated to the study of the genetics and biology of pheochromocytomas and paragangliomas in the Paris-Cardiovascular Research Centre of the Georges Pompidou Hospital (HEGP) in Paris. She particularly focuses on inherited forms of the disease caused by mutations in genes encoding the mitochondrial enzyme succinate dehydrogenase (SDH) and their role in pseudo-hypoxia, epithelial-to mesenchymal transition and epigenetic modifications. Thanks to the wide collection of tumours of the COMETE network and to the unique experimental models generated in the lab, she has made pioneering discoveries in the field.

Judith Favier is the actual co-chair of the Pheochromocytoma Research Support Organization (PRESSOR).

Supported By